LivaNova (LIVN) Net Income towards Common Stockholders Growth (3y) (2017 - 2026)
LivaNova (LIVN) Net Income towards Common Stockholders Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 17.54% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 351.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 351.22% |
| Mar 31, 2026 | 46.26% |
| Dec 31, 2025 | 163.49% |
| Sep 30, 2025 | 31.03% |
| Jun 30, 2025 | 18.12% |
| Mar 31, 2025 | -379.07% |
| Dec 31, 2023 | 226.62% |
| Mar 31, 2023 | 111.30% |
| Dec 31, 2022 | 108.30% |
| Jun 30, 2022 | 352.44% |
| Dec 31, 2020 | 81.62% |
| Mar 31, 2020 | 20.17% |
| Dec 31, 2019 | 26.16% |
| Jun 30, 2019 | 26.97% |
| Dec 31, 2018 | 59.06% |
| Dec 31, 2017 | -174.79% |